SCHEMBL1664463

SCHEMBL1664463

CN(C)c1ccc(Nc2ccc(-n3ccc4cc(NC(=O)c5ccc(N(C)C)cc5)ccc43)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 2/20 0.49
MAPT P10636 7/20 0.47
ALDH1A1 P00352 6/20 0.47
MAPK1 P28482 2/20 0.47
F2 P00734 1/20 0.46
F10 P00742 1/20 0.46
PRSS1 P07477 1/20 0.46
LMNA P02545 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MCL1 Q07820 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TP53 P04637 2/20 0.44
DHODH Q02127 1/20 0.44
NAMPT P43490 1/20 0.43
MAOB P27338 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
BTK Q06187 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664465 0.95 KCNK3 (0.51) KCNK3MAPTALDH1A1MAPK1F2
SCHEMBL1664263 0.91 KCNK3 (0.47) KCNK3MAPTALDH1A1MAPK1F2
SCHEMBL1666124 0.87 KMT2A (0.48) KCNK3MAPTALDH1A1MAPK1LMNA
SCHEMBL1665231 0.87 MAPT (0.58) MAPTALDH1A1MAPK1LMNAKDM4E
SCHEMBL1664999 0.84 MAPT (0.60) MAPTALDH1A1MAPK1LMNAKDM4E
SCHEMBL17063208 0.82 F2 (0.40) KCNK3MAPTALDH1A1MAPK1F2
SCHEMBL1665002 0.81 MAPT (0.62) MAPTALDH1A1MAPK1LMNAKDM4E
SCHEMBL1663505 0.80 MAOB (0.54) KCNK3MAPTALDH1A1MAPK1LMNA
SCHEMBL1663515 0.79 KCNK3 (0.46) KCNK3MAPTALDH1A1MAPK1LMNA
SCHEMBL1664455 0.77 HPGDS (0.46) MAPTALDH1A1F2F10PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed